Normal function · from ai-gene-review (P42229, commit 79fe13b38970) · AI-generated, not KB evidence

STAT5A is a latent cytoplasmic signal transducer and sequence-specific transcription factor of the STAT family, and a close paralog of STAT5B (~90-95% identity). It is built from an N-terminal oligomerization domain, a coiled-coil domain, a p53-like DNA-binding domain, a linker, an SH2 domain, and a C-terminal transactivation domain. STAT5A is activated downstream of numerous cytokine and hormone receptors: the common gamma-chain cytokines IL-2, IL-4, IL-7, IL-9 and IL-15 (via JAK1/JAK3), IL-3/IL-5/GM-CSF, prolactin, growth hormone, erythropoietin and thrombopoietin (via JAK2), and oncogenic tyrosine kinases such as KIT and FLT3. Receptor-associated JAK kinases phosphorylate STAT5A on Tyr-694; the phosphorylated protein dimerizes through reciprocal SH2-phosphotyrosine interactions (forming homodimers, higher-order tetramers, and heterodimers with STAT5B or STAT3), translocates from the cytoplasm to the nucleus, and binds gamma-activated sequence (GAS) DNA elements to activate RNA polymerase II transcription of target genes, recruiting coactivators such as NCOA1/SRC-1 and CBP/p300. Tyrosine phosphorylation is required for DNA binding and dimerization, and serine phosphorylation for maximal transcriptional activity; signaling is terminated by SOCS/CIS proteins, phosphatases, and nuclear export. STAT5A is the mammary-predominant STAT5 paralog and a central effector of prolactin-PRLR-JAK2 signaling driving alveolar differentiation and milk-protein expression during lactation, and it also contributes, largely redundantly with STAT5B, to hematopoietic and lymphoid cell proliferation, survival and differentiation and to immune homeostasis.

Cytokine/hormone-receptor-activated, sequence-specific RNA polymerase II transcription factor: upon JAK-mediated phosphorylation at Tyr-694 and SH2-dependent dimerization, activated STAT5A binds gamma-activated sequence (GAS) elements in cis-regulatory regions of target genes and activates their transcription, recruiting coactivators (NCOA1/SRC-1, CBP/p300).
Phosphotyrosine-dependent signal transduction: the SH2 domain of latent cytoplasmic STAT5A recognizes phosphotyrosine residues on activated cytokine/hormone receptors and, reciprocally, on the partner STAT5 monomer (Tyr-694), forming the activated dimer that couples receptor-associated JAK activation to nuclear translocation and DNA binding.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Cowden Syndrome no genetic record
animal model: Mammary Pten loss with constitutive Stat5 activation
Growth Hormone Insensitivity Syndrome no genetic record
mechanism: GH-IGF1 Axis Disruption
subtype: STAT5A Deficiency
Parvovirus B19 Infection no genetic record
mechanism: EPO-STAT5 Signaling Pathway

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.